We demonstrated that FICD overexpression using transgenic FICD knock-in mice affected osteoclasts with no effect on disease activity, while inhibiting c-FMS signaling attenuated both disease activity and arthritic bone erosion in murine arthritis models. The gene discussed is CSF1R; the disease is Arthritis.